|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.71 USD | -5.18% |
|
-2.36% | +6.34% |
| 11/02 | JPMorgan Adjusts Price Target on Fortive to $63 From $57, Maintains Underweight Rating | MT |
| 09/02 | Barclays Adjusts Price Target on Fortive to $63 From $56, Maintains Equalweight Rating | MT |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.37 | 3.41 | 3.97 | 4.31 | 4.21 | |||||
Return on Total Capital | 2.9 | 4.1 | 4.79 | 5.19 | 5.06 | |||||
Return On Equity % | 17.74 | 6.64 | 7.86 | 8.65 | 8.12 | |||||
Return on Common Equity | 16.92 | 6.28 | 7.87 | 8.66 | 8.12 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 56.46 | 57.28 | 57.73 | 59.26 | 59.87 | |||||
SG&A Margin | 35.87 | 33.63 | 33.22 | 34.05 | 34.89 | |||||
EBITDA Margin % | 21.96 | 24.43 | 25.61 | 26.18 | 27.07 | |||||
EBITA Margin % | 20.36 | 23.01 | 24.18 | 24.75 | 25.61 | |||||
EBIT Margin % | 13.68 | 16.9 | 17.62 | 18.64 | 18.34 | |||||
Income From Continuing Operations Margin % | 31.34 | 11.69 | 12.96 | 14.27 | 13.37 | |||||
Net Income Margin % | 34.81 | 11.58 | 12.96 | 14.27 | 13.37 | |||||
Net Avail. For Common Margin % | 29.85 | 11.03 | 12.96 | 14.27 | 13.37 | |||||
Normalized Net Income Margin | 6.54 | 9.2 | 9.79 | 10.21 | 9.35 | |||||
Levered Free Cash Flow Margin | 24.68 | 15.71 | 19.6 | 18.82 | 19.69 | |||||
Unlevered Free Cash Flow Margin | 26.68 | 16.94 | 20.66 | 20.09 | 21.22 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.28 | 0.32 | 0.36 | 0.37 | 0.37 | |||||
Fixed Assets Turnover | 7.75 | 8.89 | 10.09 | 10.29 | 10.46 | |||||
Receivables Turnover (Average Receivables) | 5.45 | 6.04 | 6.17 | 5.75 | 5.85 | |||||
Inventory Turnover (Average Inventory) | 4.63 | 4.64 | 4.69 | 4.6 | 4.62 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.55 | 0.68 | 0.91 | 2.05 | 1.16 | |||||
Quick Ratio | 1.31 | 0.47 | 0.61 | 1.65 | 0.84 | |||||
Operating Cash Flow to Current Liabilities | 0.5 | 0.26 | 0.48 | 0.76 | 0.68 | |||||
Days Sales Outstanding (Average Receivables) | 67.17 | 60.45 | 59.17 | 63.47 | 62.61 | |||||
Days Outstanding Inventory (Average Inventory) | 79.06 | 78.71 | 77.78 | 79.29 | 79.15 | |||||
Average Days Payable Outstanding | 82.72 | 82.35 | 86.68 | 90.95 | 93.81 | |||||
Cash Conversion Cycle (Average Days) | 63.51 | 56.82 | 50.26 | 51.81 | 47.96 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 49.39 | 43.54 | 35.31 | 36.9 | 38.03 | |||||
Total Debt / Total Capital | 33.06 | 30.33 | 26.09 | 26.95 | 27.55 | |||||
LT Debt/Equity | 33.26 | 20.46 | 24.59 | 36.54 | 33.97 | |||||
Long-Term Debt / Total Capital | 22.27 | 14.25 | 18.17 | 26.69 | 24.61 | |||||
Total Liabilities / Total Assets | 44.1 | 42.2 | 39.03 | 38.95 | 40.08 | |||||
EBIT / Interest Expense | 4.27 | 8.61 | 10.44 | 9.16 | 7.48 | |||||
EBITDA / Interest Expense | 7.26 | 13.02 | 15.75 | 13.25 | 11.37 | |||||
(EBITDA - Capex) / Interest Expense | 6.75 | 12.54 | 14.77 | 12.38 | 10.59 | |||||
Total Debt / EBITDA | 4.11 | 3.08 | 2.21 | 2.33 | 2.23 | |||||
Net Debt / EBITDA | 1.38 | 2.47 | 1.75 | 1.17 | 1.76 | |||||
Total Debt / (EBITDA - Capex) | 4.42 | 3.2 | 2.36 | 2.49 | 2.4 | |||||
Net Debt / (EBITDA - Capex) | 1.48 | 2.57 | 1.87 | 1.26 | 1.89 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 1.54 | 13.38 | 10.87 | 4.11 | 2.75 | |||||
Gross Profit, 1 Yr. Growth % | 4.79 | 15.03 | 11.74 | 6.86 | 3.81 | |||||
EBITDA, 1 Yr. Growth % | 8.73 | 26.12 | 21.82 | 7.9 | 6.25 | |||||
EBITA, 1 Yr. Growth % | 10.3 | 28.11 | 22.48 | 8.17 | 6.33 | |||||
EBIT, 1 Yr. Growth % | 6.59 | 40.14 | 23.78 | 12.44 | 1.07 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 441.66 | -57.71 | 22.96 | 14.65 | -3.8 | |||||
Net Income, 1 Yr. Growth % | 118.34 | -62.29 | 24.13 | 14.65 | -3.8 | |||||
Normalized Net Income, 1 Yr. Growth % | 8.01 | 59.3 | 27.72 | 10.21 | -5.92 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 585.61 | -59.21 | 27.16 | 15.82 | -2.88 | |||||
Accounts Receivable, 1 Yr. Growth % | -9.03 | 14.8 | 3.04 | 2.72 | -0.51 | |||||
Inventory, 1 Yr. Growth % | 9.44 | 12.56 | 4.68 | 0.04 | 1.47 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.39 | -6.48 | 2.24 | 1.87 | 0.39 | |||||
Total Assets, 1 Yr. Growth % | -7.96 | 2.58 | -3.49 | 6.43 | 0.62 | |||||
Tangible Book Value, 1 Yr. Growth % | -50.79 | 109.42 | -19.19 | -31.2 | 68.52 | |||||
Common Equity, 1 Yr. Growth % | 21.35 | 6.11 | 1.8 | 6.56 | -1.26 | |||||
Cash From Operations, 1 Yr. Growth % | 13 | -33.1 | 35.59 | 3.87 | 12.8 | |||||
Capital Expenditures, 1 Yr. Growth % | 1.61 | -33.95 | 91.6 | 12.53 | 11.69 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 281.53 | -27.84 | 44.8 | 1.12 | 7.49 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 217.96 | -28.04 | 41.06 | 2.38 | 8.51 | |||||
Dividend Per Share, 1 Yr. Growth % | 0 | 0 | 0 | 3.57 | 10.34 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 10.43 | 7.3 | 12.12 | 7.44 | 3.43 | |||||
Gross Profit, 2 Yr. CAGR % | 9.36 | 9.79 | 13.37 | 9.33 | 5.32 | |||||
EBITDA, 2 Yr. CAGR % | 8.6 | 17.1 | 25.47 | 14.73 | 7.07 | |||||
EBITA, 2 Yr. CAGR % | 9.07 | 18.87 | 26.97 | 15.19 | 7.25 | |||||
EBIT, 2 Yr. CAGR % | -4.08 | 22.22 | 34.93 | 18.11 | 6.6 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 72.12 | 51.36 | -27.89 | 18.73 | 5.02 | |||||
Net Income, 2 Yr. CAGR % | -25.59 | -9.26 | -31.58 | 19.29 | 5.02 | |||||
Normalized Net Income, 2 Yr. CAGR % | -10.97 | 31.17 | 48.21 | 19.36 | 1.82 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 76.4 | 67.23 | -27.98 | 21.36 | 6.06 | |||||
Accounts Receivable, 2 Yr. CAGR % | -17.66 | 2.19 | 8.76 | 7.19 | 1.09 | |||||
Inventory, 2 Yr. CAGR % | -10.96 | 10.99 | 8.55 | 2.33 | 0.75 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 2.96 | -1.2 | -2.22 | 2.05 | 1.12 | |||||
Total Assets, 2 Yr. CAGR % | 11.52 | -2.83 | -0.5 | 1.35 | 3.48 | |||||
Tangible Book Value, 2 Yr. CAGR % | -8.51 | 1.52 | 30.09 | -25.44 | 7.68 | |||||
Common Equity, 2 Yr. CAGR % | 16.58 | 13.48 | 3.93 | 4.15 | 2.58 | |||||
Cash From Operations, 2 Yr. CAGR % | 3.38 | -13.06 | -4.76 | 18.68 | 8.24 | |||||
Capital Expenditures, 2 Yr. CAGR % | 4.07 | -18.08 | 12.5 | 46.83 | 12.11 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 33.35 | 65.93 | 1.88 | 21.22 | 4.25 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 33.73 | 51.27 | 0.44 | 20.35 | 5.4 | |||||
Dividend Per Share, 2 Yr. CAGR % | 0 | 0 | 0 | 1.77 | 6.9 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -6.97 | 11.41 | 8.48 | 9.38 | 5.85 | |||||
Gross Profit, 3 Yr. CAGR % | -3.63 | 11.22 | 10.44 | 11.16 | 7.45 | |||||
EBITDA, 3 Yr. CAGR % | -8.64 | 14.15 | 16.81 | 18.76 | 11.83 | |||||
EBITA, 3 Yr. CAGR % | -8.73 | 15.08 | 18.08 | 19.77 | 12.16 | |||||
EBIT, 3 Yr. CAGR % | -18.63 | 8.84 | 19.96 | 26.11 | 12.13 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 17.98 | 7.81 | 41.23 | -15.84 | 10.69 | |||||
Net Income, 3 Yr. CAGR % | 15.59 | -40.67 | 0.73 | -18.74 | 11.04 | |||||
Normalized Net Income, 3 Yr. CAGR % | -23.78 | 8.08 | 26.62 | 33.62 | 10.25 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 17.24 | 8.27 | 52.64 | -15.62 | 12.67 | |||||
Accounts Receivable, 3 Yr. CAGR % | -7.4 | -8.01 | 2.48 | 9.67 | 4.56 | |||||
Inventory, 3 Yr. CAGR % | -3.49 | -3.72 | 8.85 | 5.63 | 2.04 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 0.02 | -0.29 | -0.06 | -0.88 | 1.5 | |||||
Total Assets, 3 Yr. CAGR % | 15.2 | 8.46 | -3.05 | 1.76 | 1.1 | |||||
Tangible Book Value, 3 Yr. CAGR % | -5.95 | 20.57 | -5.92 | 5.2 | -2.15 | |||||
Common Equity, 3 Yr. CAGR % | 33.23 | 12.98 | 9.44 | 4.8 | 2.32 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.89 | -10.58 | 0.83 | -1.97 | 16.68 | |||||
Capital Expenditures, 3 Yr. CAGR % | -12 | -10.57 | 8.74 | 12.51 | 34.04 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 22.8 | 8.67 | 56.17 | 1.24 | 16.45 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 22.47 | 8.77 | 45.72 | 0.72 | 16.27 | |||||
Dividend Per Share, 3 Yr. CAGR % | 0 | 0 | 0 | 1.18 | 4.55 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -5.59 | -0.46 | 0.24 | 9.8 | 6.43 | |||||
Gross Profit, 5 Yr. CAGR % | -2.74 | 2.26 | 2.84 | 10.44 | 8.36 | |||||
EBITDA, 5 Yr. CAGR % | -7.1 | 0.73 | 2.26 | 12.97 | 12.5 | |||||
EBITA, 5 Yr. CAGR % | -7.36 | 0.79 | 2.56 | 13.61 | 13.28 | |||||
EBIT, 5 Yr. CAGR % | -13.3 | -3.78 | -2.69 | 10.42 | 13.96 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 10.95 | -3.66 | -3.11 | 12.05 | 25.45 | |||||
Net Income, 5 Yr. CAGR % | 13.31 | -6.95 | -6.28 | -21.55 | 2.42 | |||||
Normalized Net Income, 5 Yr. CAGR % | -17.81 | -5.59 | -3.6 | 10.1 | 15.71 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 10.1 | -4.98 | -3.52 | 13.33 | 31.95 | |||||
Accounts Receivable, 5 Yr. CAGR % | -3.72 | -0.32 | -1.25 | -2.21 | 3.61 | |||||
Inventory, 5 Yr. CAGR % | -2.72 | -1.2 | 1.16 | -1.34 | 5.53 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 3.48 | 0.84 | -0.88 | 0.64 | 0.41 | |||||
Total Assets, 5 Yr. CAGR % | 17.36 | 14.99 | 8.64 | 5.56 | -0.49 | |||||
Tangible Book Value, 5 Yr. CAGR % | 29.02 | 11.61 | 7.08 | -0.51 | -0.7 | |||||
Common Equity, 5 Yr. CAGR % | 11.6 | 28.76 | 20.63 | 9.36 | 6.64 | |||||
Cash From Operations, 5 Yr. CAGR % | 7.32 | -3.3 | 2.07 | 0.14 | 3.73 | |||||
Capital Expenditures, 5 Yr. CAGR % | -8.82 | -14.6 | -2.92 | 9.05 | 10.08 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 2.15 | 0.95 | 13.07 | 12.16 | 32.56 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 3.75 | 1.74 | 12.32 | 12 | 27.73 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | 14.87 | 0 | 0.7 | 2.71 |
- Stock Market
- Equities
- FTV Stock
- Financials Fortive Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















